Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials

INTRODUCTION: This meta-analysis of data from 14 phase 2 and 3, double-blind, randomized, controlled 12- and 24-week studies (N = 4632) summarizes saxagliptin efficacy in patients with type 2 diabetes (T2D) across treatment regimens. METHODS: Patients received saxagliptin 5 mg/d or control as either...

Descripción completa

Detalles Bibliográficos
Autores principales: Sjöstrand, Mikaela, Wei, Cheryl, Cook, William, Johnsson, Kristina, Pollack, Pia S., Stahre, Christina, Hirshberg, Boaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446386/
https://www.ncbi.nlm.nih.gov/pubmed/28432619
http://dx.doi.org/10.1007/s13300-017-0261-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446386/
https://www.ncbi.nlm.nih.gov/pubmed/28432619
http://dx.doi.org/10.1007/s13300-017-0261-8

Ejemplares similares